StockWatch
·
Medical/Nursing Services
Quarterly ResultMay 5, 2026, 04:15 PM

InnovAge Q3 Revenue $251.9M, Adj. EBITDA $30.5M; Raises FY26 Guidance

AI Summary

InnovAge Holding Corp. announced financial results for its fiscal third quarter ended March 31, 2026, reporting a 15.5% increase in total revenues to $251.9 million and a significant rise in Adjusted EBITDA to $30.5 million. Despite a net loss of $29.9 million, the company raised its full fiscal year 2026 guidance for both total revenues and Adjusted EBITDA, citing continued operational improvements.

Key Highlights

  • Total revenues increased 15.5% to $251.9 million in Q3 FY26 from $218.1 million in Q3 FY25.
  • Adjusted EBITDA rose 182.9% to $30.5 million in Q3 FY26 from $10.8 million in Q3 FY25.
  • Reported a net loss of $29.9 million, or $(0.22) per share, in Q3 FY26.
  • Center-level Contribution Margin grew 49.8% to $61.0 million in Q3 FY26.
  • Census increased to approximately 8,050 participants in Q3 FY26 from 7,530 in Q3 FY25.
  • Raised full fiscal year 2026 revenue guidance to $950 million - $975 million.
  • Raised full fiscal year 2026 Adjusted EBITDA guidance to $85 million - $90 million.
  • Ended Q3 FY26 with $95.5 million in cash and cash equivalents.